The UK Stem Cell Bank 

• Banking- Acting as the sole public repository of all UK-derived human embryonic stem cell lines, holding over 180 stem cell lines and distributing research and clinical (European Union Tissue and Cells Directives, EUTCD) grade lines.
• Research- Undertaking research to improve the standardisation, quality and safety of human pluripotent stem cell (hPSC)-based products, collaborating with international partners to deliver projects supporting the development of stem cell therapies and developing WHO reference materials for Advanced Therapies.
• Regulation- Being active in the UK regenerative medicine infrastructure, providing support and advice on international best practice, policies and guidelines relating to stem cell use and regulation around the world.

How can we help

For more information, comments, complaints and resupply contact us at enquiriesmail@mhra.gov.uk.

Sign up to the UK Stem Cell Bank newsletter to receive regular updates about our work. 

The Medical Research Council (MRC) acted as secretariat for the steering committee between January 2003 and February 2023, and as such held all data relating to the steering committee. From March 2023, all records held for data subjects were transferred to the current secretariat at the Medicines and Healthcare products Regulatory Agency (MHRA). Any Data Subject Rights or any Data Protection related queries should be directed to MHRA

Our staff

Chris Burns – Head of Biotherapeutics and Advanced Therapies and HTA Designated Individual

UK Stem Cell Bank Team

Lee Carpenter – Head of UK Stem Cell Bank
Clare Wise – Head of Cell Production
Elisa Mattioli – Cell Supply Lead
Andrew Choy – Scientist, Stem Cell Production
Judith Prince – Quality Co-ordinator (HTA Human Application / Tissue)
Adrian Zarzoso – Scientific Project Manager

Cell Therapy Team

Kate Warre Cornish – Head of Cell Therapy
Leo Perfect – Cell Therapy Specialist
Luke Lindsay-Hill – Senior Scientist